Intrinsic value of Acrivon Therapeutics, Inc. Common Stock (ACRV)
Live fair value data for Acrivon Therapeutics, Inc. Common Stock (ACRV) is currently unavailable. Please check again shortly.
Current Price: $70.00
Valuation: Undervalued
Confidence: 8.0/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is Acrivon Therapeutics, Inc. Common Stock (ACRV) undervalued or overvalued?
Based on the current model output, Acrivon Therapeutics, Inc. Common Stock appears to be undervalued with a upside of 48.00%.
Fair value vs market price — Acrivon Therapeutics, Inc. Common Stock (ACRV)
Unlock premium access to view the live fair value comparison against current market price for ACRV.
Frequently Asked Questions - ACRV
How is ACRV intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for ACRV.
Is ACRV undervalued or overvalued right now?
ACRV is currently shown as undervalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for ACRV: open their intrinsic value pages.